Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 23 EP applications Jörg Velker has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after February 22, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11758563

PROLINE SULFONAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/401, A61K 31/4025, A61K 31/535, A61P 3/00, A61P 25/00, A61P 25/30, A61P 39/00
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
GRANT OF PATENT INTENDED
EP11778981

DIASTEREOSELECTIVE PREPARATION OF BICYCLO[2.2.2]OCTAN-2-ONE COMPOUNDS

IPC classification:
C07C 305/20
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
EXAMINATION IN PROGRESS
EP12791862

2-(1,2,3-TRIAZOL-2-YL)BENZAMIDE AND 3-(1,2,3-TRIAZOL-2-YL)PICOLINAMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/5377, A61P 3/04, A61P 25/22, A61P 25/26, A61P 25/30, C07D 413/10, C07D 413/14, C07D 417/14
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13744805

BENZIMIDAZOLE-PROLINE DERIVATIVES

IPC classification:
A61K 31/4184, A61K 31/426, A61K 31/505, A61P 25/00, C07D 401/14, C07D 403/04, C07D 417/14
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
PATENT GRANTED
EP13197481

Stereoselective synthesis of substituted pyrrolidines

IPC classification:
C07B 53/00, C07D 207/12, C07D 207/16, C07D 491/08
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15154003

Oxazolidinone antibiotics

IPC classification:
A61K 31/435, A61P 31/00, C07D 471/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
PATENT GRANTED
EP13805561

OREXIN RECEPTOR ANTAGONISTS WHICH ARE [ORTHO BI (HETERO )ARYL]-[2-(META BI (HETERO)ARYL)-PYRROLIDIN-1-YL]-METHANONE DERIVATIVES

IPC classification:
A61K 31/41, A61P 25/00, C07D 401/14, C07D 403/04, C07D 403/14, C07D 413/04, C07D 413/14, C07D 417/04, C07D 417/14, C07D 419/04, C07D 419/14
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
GRANT OF PATENT INTENDED
EP15154086

Oxazolidinone antibiotics

IPC classification:
A61K 31/435, A61P 31/00, C07D 471/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
PATENT GRANTED
EP14714392

AZETIDINE AMIDE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/397, A61K 31/4155, A61K 31/4178, A61K 31/4192, A61K 31/4196, A61K 31/422, A61K 31/4245, A61K 31/427, A61K 31/433, A61P 25/00, C07D 413/04, C07D 413/14, C07D 417/14
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
EXAMINATION IN PROGRESS
EP14721539

ANTIBACTERIAL BIAROMATIC DERIVATIVES

IPC classification:
A61K 31/538, A61K 31/5383, A61K 31/5415, A61K 31/542, A61P 31/00, C07D 413/04, C07D 413/14, C07D 417/04, C07D 417/14, C07D 498/04, C07D 513/04
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
The patent has been granted
EP14726420

QUINOLONE DERIVATIVES

IPC classification:
A61K 31/424, A61K 31/429, A61K 31/4353, A61P 31/04, C07D 498/04, C07D 513/04, C07D 519/00
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
EXAMINATION IN PROGRESS
EP14730591

CXCR7 RECEPTOR MODULATORS

IPC classification:
A61K 31/455, C07D 211/56, C07D 405/12
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
The patent has been granted
EP11820868

LACTAM DERIVATIVES USEFUL AS OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/397, A61K 31/4015, A61K 31/451, A61K 31/4709, A61P 3/04, A61P 25/20, A61P 25/30, C07D 207/26, C07D 215/08, C07D 215/14, C07D 401/06, C07D 417/06
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14799475

TRICYCLIC IMIDAZOLE COMPOUNDS AS INHIBITORS OF TRYPTOPHAN HYDROXYLASE

IPC classification:
A61K 31/453, A61K 31/4535, A61K 31/454, A61K 31/4545, A61P 1/00, A61P 3/10, A61P 9/12, A61P 11/00, A61P 19/10, A61P 25/00, A61P 35/00, C07D 471/04, C07D 471/14, C07D 498/12, C07D 513/14
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
The patent has been granted
EP14799473

TRICYCLIC PIPERIDINE COMPOUNDS

IPC classification:
A61K 31/437, A61P 11/06, C07D 513/14
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Status:
The patent has been granted
EP14824107

CRYSTALLINE FORM OF (S)-(2-(6-CHLORO-7-METHYL-1H-BENZO[D]IMIDAZOL-2-YL)-2-METHYLPYRROLIDIN-1 -YL)(5-METHOXY-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE AND ITS USE AS OREXIN RECEPTOR ANTAGONISTS

IPC classification:
A61K 31/4192, A61P 25/00, C07D 403/14
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
The patent has been granted
EP14824108

CRYSTALLINE SALT FORM OF (S)-(2-(6-CHLORO-7-METHYL-1 H-BENZO[D]IMIDAZOL-2-YL)-2-METHYLPYRROLIDIN-1 -YL)(5-METHOXY-2-(2H-1,2,3-TRIAZOL-2-YL)PHENYL)METHANONE AS OREXIN RECEPTOR ANTAGONIST

IPC classification:
A61K 31/4192, A61P 25/00, C07D 403/14
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
The patent has been granted
EP14827273

USE OF BENZIMIDAZOLE-PROLINE DERIVATIVES

IPC classification:
A61K 31/4178, A61K 31/4192, A61K 31/506, A61P 25/00, C07D 403/14
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
EXAMINATION REQUESTED
EP12709375

NOVEL PYRAZOLE AND IMIDAZOLE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS

IPC classification:
A61K 31/4155, A61K 31/4178, A61K 31/422, A61P 25/00, C07D 413/12, C07D 413/14, C07D 417/12, C07D 417/14
Applicant:
Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15706185

PROCESS FOR MANUFACTURING PYRIMIDINE SULFAMIDE DERIVATIVES

IPC classification:
C07D 401/12
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
EXAMINATION REQUESTED
EP15778983

ANTIBACTERIAL BASIC BIAROMATIC DERIVATIVES WITH AMINOALKOXY SUBSTITUTION

IPC classification:
A61K 31/5365, A61P 31/04, C07D 417/14, C07D 498/04
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
Request for examination was made
EP15801263

ANTIBACTERIAL BENZOTHIAZOLE DERIVATIVES

IPC classification:
A61K 31/428, A61P 31/04, C07D 277/62
Agent:
Multiple attorneys, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
Request for examination was made
EP15801467

CXCR7 RECEPTOR MODULATORS

IPC classification:
A61K 31/55, A61K 31/5513, A61K 31/553, C07D 223/16, C07D 243/14, C07D 267/14
Agent:
Jörg Velker, Actelion Pharmaceuticals Ltd.
Agent:
Jörg Velker, Idorsia Pharmaceuticals Ltd
Status:
Request for examination was made

Please Sign in to use this feature